8-K Announcements
6Material company update
Mar 12, 2026·SEC
Material company update
Mar 10, 2026·SEC
Material company update
Feb 6, 2026·SEC
Agape ATP Corporation(ATPC)Earnings, Financials & Key Ratios
ATPC•NASDAQ
$2.87
Price updated Jul 7, 2026
AboutAgape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.Show more
- Revenue$2M+15.2%
- EBITDA-$3M-29.1%
- Net Income-$2M+7.7%
- EPS (Diluted)-2.85+91.0%
- Gross Margin53.67%-6.5%
- EBITDA Margin-198.7%-12.0%
- Operating Margin-213.65%-9.8%
- Net Margin-149.57%+19.9%
- ROE-18.72%+76.1%
ATPC Price & Volume
Agape ATP Corporation (ATPC) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operational Losses Threaten Corporate Solvency
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Severe liquidity and solvency
Key Thesis Takeaways
- Agape ATP Corporation faces a critical liquidity crisis characterized by a decade of consistent net losses and an eroding cash position that fell from $4.8M in 2023Q4 to $218.9K by 2026Q1.
- While the company maintains gross margins above 50%, its inability to scale revenue beyond $273.7K in 2026Q1 while burdened by excessive SG&A expenses suggests a fundamental lack of operational viability.
- Investors should remain cautious as the company's reliance on external capital and lack of positive free cash flow indicate a high probability of further dilutive financing or insolvency risks.
Verdict Logic
the company's cash reserves of only $218.9K against a recurring quarterly net loss profile suggest an unsustainable path that poses a severe risk to shareholder capital.
ATPC Growth Metrics
Agape ATP Corporation (ATPC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-15.09%
3 Years-6.36%
TTM16.68%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM22.41%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM92.57%
Return on Capital
10 Years-31.4%
5 Years-54.29%
3 Years-57.01%
Last Year-26.42%
ATPC Recent Earnings
Agape ATP Corporation (ATPC) EPS & revenue vs analyst estimates — last 4 quarters
Q2 2026Latest
May 15, 2026Metric
Actual
Est
EPS
$0.33
—
Rev
$399,133
—
Q2 2026
May 13, 2026Metric
Actual
Est
EPS
$0.38
—
Rev
$399,133
—
Q2 2026
Mar 30, 2026Metric
Actual
Est
EPS
$10.00
—
Rev
$273,658
—
Q4 2025
Nov 13, 2025Metric
Actual
Est
EPS
$0.01
—
Rev
$370,593
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $0.33 | $399,133 |
| Q2 2026 | May 13, 2026 | $0.38 | $399,133 |
| Q2 2026 | Mar 30, 2026 | $10.00 | $273,658 |
| Q4 2025 | Nov 13, 2025 | $0.01 | $370,593 |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Agape ATP Corporation (ATPC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $2.87 | $2.87M | -1.01 | 15.23% | -149.57% | -18.72% | — | |
| $1.82 | $20.31M | -23.73 | -7.42% | -3.03% | -4.88% | — | |
| $0.84 | $24.98M | -3.23 | 15.17% | -3.05% | -15.02% | — | |
| $22.38 | $413.2M | 38.59 | 8.28% | 0.96% | 1.51% | — | |
| $5.17 | $251.01M | 1.63 | -14.26% | 3.78% | 6.84% | — | |
| $21.75 | $382.47M | 20.52 | 5.67% | 4.06% | 12.08% | — |
Compare ATPC vs Peers
Agape ATP Corporation (ATPC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ATPC SEC Filings & Documents
Agape ATP Corporation (ATPC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when ATPC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ATPC Frequently Asked Questions
Agape ATP Corporation (ATPC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Agape ATP Corporation's revenue?
Agape ATP Corporation (ATPC) reported $1.5M in revenue for fiscal year 2025.
How fast is Agape ATP Corporation growing?
Agape ATP Corporation (ATPC) grew revenue by 15.2% over the past year. This is strong growth.
Is ATPC profitable?
Agape ATP Corporation (ATPC) reported a net loss of $1.9M for fiscal year 2025.
Dividend & Returns
What is ATPC's return on equity?
Agape ATP Corporation (ATPC) has a return on equity (ROE) of -18.7%. Negative ROE indicates the company is unprofitable.
What is Agape ATP Corporation's free cash flow?
Agape ATP Corporation (ATPC) had negative free cash flow of $1.4M in fiscal year 2025, likely due to heavy capital investments.